<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">9866731</article-id><article-id pub-id-type="pmc">2640238</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Cell-to-cell signaling and Pseudomonas aeruginosa infections.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Van Delden</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Iglewski</surname><given-names>B. H.</given-names></name></contrib></contrib-group><aff>University of Rochester, School of Medicine and Dentistry, New York, USA.</aff><pub-date pub-type="ppub"><season>Oct-Dec</season><year>1998</year></pub-date><volume>4</volume><issue>4</issue><fpage>551</fpage><lpage>560</lpage><abstract><p>Pseudomonas aeruginosa is a bacterium responsible for severe nosocomial infections, life-threatening infections in immunocompromised persons, and chronic infections in cystic fibrosis patients. The bacterium's virulence depends on a large number of cell-associated and extracellular factors. Cell-to-cell signaling systems control the expression and allow a coordinated, cell-density-dependent production of many extracellular virulence factors. We discuss the possible role of cell-to-cell signaling in the pathogenesis of P. aeruginosa infections and present a rationale for targeting cell-to-cell signaling systems in the development of new therapeutic approaches.</p></abstract></article-meta></front></article>